Skip to main content

Can you take COVID-19 mRNA (Pfizer) vaccine with Delgocitinib topical?

1 drug interaction found for the following 2 drugs:

Add/remove drugs

Drug interactions

Moderate drug interactions

Moderate:

SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309) delgocitinib topical

Applies to: COVID-19 mRNA (Pfizer) vaccine and delgocitinib topical

If you are currently being treated or have recently been treated with delgocitinib topical, you should let your doctor know before receiving SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309). Depending on the dose and length of time you have been on delgocitinib topical, you may have a reduced response to the vaccine. In some situations, your doctor may want to alter vaccination schedule. If you have recently been vaccinated with SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309), your doctor may choose to postpone treatment with delgocitinib topical for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Food/lifestyle interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Disease interactions

No disease interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

More resources

COVID-19 mRNA (Pfizer) vaccine

A total of 388 drugs are known to interact with COVID-19 mRNA (Pfizer) vaccine.

delgocitinib topical

A total of 334 drugs are known to interact with delgocitinib topical.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.